Invention Grant
- Patent Title: Methods and compositions employing immunogenic fusion proteins
-
Application No.: US16850143Application Date: 2020-04-16
-
Publication No.: US11684664B2Publication Date: 2023-06-27
- Inventor: Elaine Tuomanen , Elizabeth R. Mann
- Applicant: St. Jude Children's Research Hospital
- Applicant Address: US TN Memphis
- Assignee: St. Jude Children's Research Hospital
- Current Assignee: St. Jude Children's Research Hospital
- Current Assignee Address: US TN Memphis
- Agency: Cooley LLP
- Agent Ivor R. Elrifi; Edith Hang Yu Cheng
- The original application number of the division: US15812361 2017.11.14
- Main IPC: A61K39/02
- IPC: A61K39/02 ; A61K39/09 ; C07K14/315 ; C07K14/47 ; A61K39/00

Abstract:
Compositions nod methods are provided for the prevention and treatment of bacterial infections, including pneumococcal infections. Compositions provided herein comprise a variety immunogenic fusion proteins, wherein at least one polypeptide component of a given fusion protein comprises a CbpA polypeptide and/or a cytolysoid polypeptide, or an active variant or fragment thereof. Methods are provided for the prevention and treatment of bacterial infections, including pneumococcal infections by employing die various immunogenic fusion proteins having at least one polypeptide component comprising a CbpA polypeptide and/or acytolysoid polypeptide, or an active variant or fragment thereof.
Public/Granted literature
- US20200246447A1 METHODS AND COMPOSITIONS EMPLOYING IMMUNOGENIC FUSION PROTEINS Public/Granted day:2020-08-06
Information query